183 related articles for article (PubMed ID: 21237236)
101. Overexpression of glutamine synthetase in human primary liver cancer.
Christa L; Simon MT; Flinois JP; Gebhardt R; Brechot C; Lasserre C
Gastroenterology; 1994 May; 106(5):1312-20. PubMed ID: 7909780
[TBL] [Abstract][Full Text] [Related]
102. Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas.
Singh Y; Port J; Schwarz M; Braeuning A
Br J Cancer; 2014 Jul; 111(1):132-8. PubMed ID: 24874479
[TBL] [Abstract][Full Text] [Related]
103. Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice.
Sekine S; Lan BY; Bedolli M; Feng S; Hebrok M
Hepatology; 2006 Apr; 43(4):817-25. PubMed ID: 16557553
[TBL] [Abstract][Full Text] [Related]
104. Intracellular localization of beta-catenin expression plays a possible prognostic role on the outcome of hepatoblastoma patients.
Celtik U; Dokumcu Z; Divarci E; Guler E; Ataseven E; Nart D; Yilmaz F; Celik A; Ergün O
Pediatr Surg Int; 2020 Jul; 36(7):817-825. PubMed ID: 32436062
[TBL] [Abstract][Full Text] [Related]
105. m
Liu L; Wang J; Sun G; Wu Q; Ma J; Zhang X; Huang N; Bian Z; Gu S; Xu M; Yin M; Sun F; Pan Q
Mol Cancer; 2019 Dec; 18(1):188. PubMed ID: 31870368
[TBL] [Abstract][Full Text] [Related]
106. ACLY-β-catenin axis modulates hepatoblastoma cell proliferation.
Lin Y; Fang H; Ma C; Zhou J; Ding M; Sun H; Xu Y; Shan Y; Gao H; Yang L; Gu S; Li H
Biochem Biophys Res Commun; 2023 Jun; 663():104-112. PubMed ID: 37121120
[TBL] [Abstract][Full Text] [Related]
107. O-GlcNAcylated LARP1 positively regulated by circCLNS1A facilitates hepatoblastoma progression through DKK4/β-catenin signalling.
Cui Z; He J; Zhu J; Ni W; Liu L; Bian Z; Mao S; Gu S; Shan Y; Chu Z; Wu Q; Lu J; Liu Y; Sun F; Pan Q; Zhang Y; Huang N; Ma J
Clin Transl Med; 2023 Apr; 13(4):e1239. PubMed ID: 37070251
[TBL] [Abstract][Full Text] [Related]
108. Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin.
Danielyan L; Zellmer S; Sickinger S; Tolstonog GV; Salvetter J; Lourhmati A; Reissig DD; Gleiter CH; Gebhardt R; Buniatian GH
PLoS One; 2009; 4(2):e4416. PubMed ID: 19204801
[TBL] [Abstract][Full Text] [Related]
109. High tricellulin expression is associated with better survival in human hepatoblastoma.
Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
[TBL] [Abstract][Full Text] [Related]
110. CITED1 expression in liver development and hepatoblastoma.
Murphy AJ; de Caestecker C; Pierce J; Boyle SC; Ayers GD; Zhao Z; Libes JM; Correa H; Walter T; Huppert SS; Perantoni AO; de Caestecker MP; Lovvorn HN
Neoplasia; 2012 Dec; 14(12):1153-63. PubMed ID: 23308048
[TBL] [Abstract][Full Text] [Related]
111. HepG2-1A2 C2 and C7: Lentivirus vector-mediated stable and functional overexpression of cytochrome P450 1A2 in human hepatoblastoma cells.
Steinbrecht S; Pfeifer N; Herzog N; Katzenberger N; Schulz C; Kammerer S; Küpper JH
Toxicol Lett; 2020 Feb; 319():155-159. PubMed ID: 31706005
[TBL] [Abstract][Full Text] [Related]
112. Allelic imbalance at the beta-catenin gene (CTNNB1 at 3p22-21.3) in various human tumor types.
Nollet F; Vandenberg A; Kersemaekers A; Cletonjansen A; Berx G; Vanderveen A; Eichperger C; Wieland I; Degreve J; Liefers G; Xiao W; Buys C; Cornelisse C; Vanroy F
Int J Oncol; 1997 Aug; 11(2):311-8. PubMed ID: 21528216
[TBL] [Abstract][Full Text] [Related]
113. Mutational landscape of hepatoblastoma goes beyond the Wnt-β-catenin pathway.
Han ZG
Hepatology; 2014 Nov; 60(5):1476-8. PubMed ID: 25078725
[No Abstract] [Full Text] [Related]
114. CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer.
Mou H; Eskiocak O; Özler KA; Gorman M; Yue J; Jin Y; Wang Z; Gao Y; Janowitz T; Meyer HV; Yu T; Wilkinson JE; Kucukural A; Ozata DM; Beyaz S
J Pathol; 2023 Apr; 259(4):415-427. PubMed ID: 36641763
[TBL] [Abstract][Full Text] [Related]
115. Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.
Kiruthiga KG; Ramakrishna B; Saha S; Sen S
J Gastrointest Oncol; 2018 Apr; 9(2):326-337. PubMed ID: 29755772
[TBL] [Abstract][Full Text] [Related]
116. Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival.
Bauer L; Langer R; Becker K; Hapfelmeier A; Ott K; Novotny A; Höfler H; Keller G
PLoS One; 2012; 7(9):e44566. PubMed ID: 22970250
[TBL] [Abstract][Full Text] [Related]
117. Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis.
Liu F; Wu Y; Zhang B; Yang S; Shang K; Li J; Zhang P; Deng W; Chen L; Zheng L; Gai X; Zhang H
Chin Med J (Engl); 2024 Jan; 137(2):181-189. PubMed ID: 37612257
[TBL] [Abstract][Full Text] [Related]
118. Heterogeneous (positional) expression of hepatic glutamine synthetase: features, regulation and implications for hepatocarcinogenesis.
Gebhardt R; Gaunitz F; Mecke D
Adv Enzyme Regul; 1994; 34():27-56. PubMed ID: 7942280
[TBL] [Abstract][Full Text] [Related]
119. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer.
Liu F; Gai X; Wu Y; Zhang B; Wu X; Cheng R; Tang B; Shang K; Zhao N; Deng W; Chen J; Zhang Z; Gu S; Zheng L; Zhang H
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2202157119. PubMed ID: 36122209
[No Abstract] [Full Text] [Related]
120. Lithium and glutamine synthetase: Protective effects following stress.
Mundorf A; Knorr A; Mezö C; Klein C; Beyer DK; Fallgatter AJ; Schwarz M; Freund N
Psychiatry Res; 2019 Nov; 281():112544. PubMed ID: 31499341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
